Clinical Trials Directory

Trials / Terminated

TerminatedNCT02694549

CaveoVasc System - a New Femoral Vascular Access and Closure Device

Prospective, Single Arm Study to Assess the Performance and Safety of CaveoVasc System for Femoral Vascular Access and Closure Device

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
CaveoMed GmbH · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to assess the performance and safety of the CaveoVasc® System for femoral vascular access and for prevention of bleeding from the femoral artery puncture site.

Conditions

Interventions

TypeNameDescription
DEVICECaveoVasc

Timeline

Start date
2016-08-09
Primary completion
2016-10-10
Completion
2016-11-10
First posted
2016-02-29
Last updated
2018-08-28
Results posted
2018-08-28

Source: ClinicalTrials.gov record NCT02694549. Inclusion in this directory is not an endorsement.

CaveoVasc System - a New Femoral Vascular Access and Closure Device (NCT02694549) · Clinical Trials Directory